Search Menu Search Our company Our business strategy We are focused on returning to growth through science-led innovation. AstraZeneca has completed the first phase in its strategic journey. We have rebuilt strong foundations for sustainable delivery and are on track to return to growth by 2017. Our efforts are creating significant value for patients and shareholders. Pascal Soriot Chief Executive Officer Achieve scientific leadership We are focusing our science on our main therapy areas and accelerating our pipeline. We are also transforming our way of working. Read more Return to growth We are focusing on our growth platforms and transforming the business through specialty care, devices and biologics. Targeted business development reinforces our efforts. Read more Be a great place to work We are evolving our culture and simplifying our business. We want to attract and retain the best talent. Read more Our most recent financial results PDF 5,943KB Inhibiting stages in the DNA damage response pathway Read more Follow us on LinkedIn Connect Follow us on Twitter Connect Sign up for email alerts Subscribe now AstraZeneca Websites This website is intended for people seeking information on AstraZeneca's worldwide business. Our country sites can be located in the AZ Network. Website Atlas ID: 1017655.011 Date of next review: October 2017 Resources Quick links Social Media Facebook LinkedIn Twitter Glassdoor utility links Legal notice and Terms of Use Privacy notice Cookie policy Site map Contact us © AstraZeneca 2017